222 related articles for article (PubMed ID: 24005194)
41. Dose Adjustment Associated Complications of Bone Morphogenetic Protein: A Longitudinal Assessment.
De Stefano FA; Elarjani T; Burks JD; Burks SS; Levi AD
World Neurosurg; 2021 Dec; 156():e64-e71. PubMed ID: 34530148
[TBL] [Abstract][Full Text] [Related]
42. Extension of spine fusion to the sacrum following long fusions for deformity correction.
OʼNeill KR; Bridwell KH; Lenke LG; Chuntarapas T; Dorward I; Neuman B; Ahmad A; Baldus C
Spine (Phila Pa 1976); 2014 May; 39(12):953-62. PubMed ID: 24718063
[TBL] [Abstract][Full Text] [Related]
43. Risk factors for and assessment of symptomatic pseudarthrosis after lumbar pedicle subtraction osteotomy in adult spinal deformity.
Dickson DD; Lenke LG; Bridwell KH; Koester LA
Spine (Phila Pa 1976); 2014 Jul; 39(15):1190-5. PubMed ID: 25171067
[TBL] [Abstract][Full Text] [Related]
44. Obesity and spine surgery: reassessment based on a prospective evaluation of perioperative complications in elective degenerative thoracolumbar procedures.
Yadla S; Malone J; Campbell PG; Maltenfort MG; Harrop JS; Sharan AD; Vaccaro AR; Ratliff JK
Spine J; 2010 Jul; 10(7):581-7. PubMed ID: 20409758
[TBL] [Abstract][Full Text] [Related]
45. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2).
McClellan JW; Mulconrey DS; Forbes RJ; Fullmer N
J Spinal Disord Tech; 2006 Oct; 19(7):483-6. PubMed ID: 17021411
[TBL] [Abstract][Full Text] [Related]
46. Complications associated with single-level transforaminal lumbar interbody fusion.
Rihn JA; Patel R; Makda J; Hong J; Anderson DG; Vaccaro AR; Hilibrand AS; Albert TJ
Spine J; 2009 Aug; 9(8):623-9. PubMed ID: 19482519
[TBL] [Abstract][Full Text] [Related]
47. Posterior Cervical Fusion With Recombinant Human Bone Morphogenetic Protein-2: Complications and Fusion Rate at Minimum 2-Year Follow-Up.
Dorward IG; Buchowski JM; Stoker GE; Zebala LP
Clin Spine Surg; 2016 Jul; 29(6):E276-81. PubMed ID: 27137152
[TBL] [Abstract][Full Text] [Related]
48. Complications with recombinant human bone morphogenic protein-2 in posterolateral spine fusion: a consecutive series of 1037 cases.
Glassman SD; Howard J; Dimar J; Sweet A; Wilson G; Carreon L
Spine (Phila Pa 1976); 2011 Oct; 36(22):1849-54. PubMed ID: 20838369
[TBL] [Abstract][Full Text] [Related]
49. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
Burkus JK; Gornet MF; Glassman SD; Slosar PJ; Rosner MK; Deckey JE; Nowak J; Hatcher BM
Spine (Phila Pa 1976); 2011 Dec; 36(25):2158-67. PubMed ID: 21325990
[TBL] [Abstract][Full Text] [Related]
50. Anterior thoracolumbar spine exposure: critical review and analysis.
Ballard JL; Carlson G; Chen J; White J
Ann Vasc Surg; 2014 Feb; 28(2):465-9. PubMed ID: 24378244
[TBL] [Abstract][Full Text] [Related]
51. Adjuncts in posterior lumbar spine fusion: comparison of complications and efficacy.
Hoffmann MF; Jones CB; Sietsema DL
Arch Orthop Trauma Surg; 2012 Aug; 132(8):1105-10. PubMed ID: 22562366
[TBL] [Abstract][Full Text] [Related]
52. Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery.
Tannoury CA; An HS
Spine J; 2014 Mar; 14(3):552-9. PubMed ID: 24412416
[TBL] [Abstract][Full Text] [Related]
53. Pseudo-Pedicle Heterotopic Ossification From Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) in Transforaminal Lumbar Interbody Fusion Cages.
Rosen CD; Kiester PD; Lee TQ
Am J Orthop (Belle Mead NJ); 2018 Jan; 47(1):. PubMed ID: 29447305
[TBL] [Abstract][Full Text] [Related]
54. Adult spinal deformity surgery: complications and outcomes in patients over age 60.
Daubs MD; Lenke LG; Cheh G; Stobbs G; Bridwell KH
Spine (Phila Pa 1976); 2007 Sep; 32(20):2238-44. PubMed ID: 17873817
[TBL] [Abstract][Full Text] [Related]
55. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2.
Villavicencio AT; Burneikiene S; Nelson EL; Bulsara KR; Favors M; Thramann J
J Neurosurg Spine; 2005 Dec; 3(6):436-43. PubMed ID: 16381205
[TBL] [Abstract][Full Text] [Related]
56. Major complications in revision adult deformity surgery: risk factors and clinical outcomes with 2- to 7-year follow-up.
Cho SK; Bridwell KH; Lenke LG; Yi JS; Pahys JM; Zebala LP; Kang MM; Cho W; Baldus CR
Spine (Phila Pa 1976); 2012 Mar; 37(6):489-500. PubMed ID: 21587110
[TBL] [Abstract][Full Text] [Related]
57. Comparison of a calcium phosphate bone substitute with recombinant human bone morphogenetic protein-2: a prospective study of fusion rates, clinical outcomes and complications with 24-month follow-up.
Parker RM; Malham GM
Eur Spine J; 2017 Mar; 26(3):754-763. PubMed ID: 28028645
[TBL] [Abstract][Full Text] [Related]
58. Intraoperative and perioperative complications in minimally invasive transforaminal lumbar interbody fusion: a review of 513 patients.
Wong AP; Smith ZA; Nixon AT; Lawton CD; Dahdaleh NS; Wong RH; Auffinger B; Lam S; Song JK; Liu JC; Koski TR; Fessler RG
J Neurosurg Spine; 2015 May; 22(5):487-95. PubMed ID: 25700243
[TBL] [Abstract][Full Text] [Related]
59. Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost?
Mannion RJ; Nowitzke AM; Wood MJ
Spine J; 2011 Jun; 11(6):527-33. PubMed ID: 20739225
[TBL] [Abstract][Full Text] [Related]
60. Effects of age on perioperative complications of extensive multilevel thoracolumbar spinal fusion surgery.
Cloyd JM; Acosta FL; Cloyd C; Ames CP
J Neurosurg Spine; 2010 Apr; 12(4):402-8. PubMed ID: 20367376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
